30 Day FDA Drug Development in Ca...

30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 17 Critical Material Attributes (CMAs) in Cannabis and Psychedelic Manufacturi

Cannabinoid and Psychedelic Pharmacology and Drug Developmen... por Jim Mitchell and Google NotebookLM
T4 · E20
31 ene 2025
17:28

Notas del episodio

This podcast episode explores Critical Material Attributes (CMAs) in botanical drug manufacturing, focusing on cannabis and psychedelics. The discussion covers key aspects including:

- The unique challenges of working with botanical materials compared to synthetic drugs

- Important CMAs like moisture content, particle size, and microbial load that affect product quality

- How cultivar selection impacts chemical profiles and final product characteristics

The episode emphasizes how consistent CMAs are fundamental to ensuring product safety, quality, and regulatory compliance in botanical drug manufacturing